We’re delighted to announce that Annalise Enterprise CXR has been granted CE Mark under MDR class IIb for clinical use in the European Union. Annalise Enterprise CXR is the most comprehensive AI decision-support solution for chest X-rays to have received CE Marking under MDR to date.

“The MDR Class IIb CE Marking is a more rigorous assessment of medical device patient safety for radiology in EU and its award is a testament to our commitment to deliver quality comprehensive solutions.” comments Dr Rick Abramson, Chief Medical Officer at Annalise.ai.